Under the Agreement, QUB assigned to the Company all of QUB's right, title, and interest in the patent rights previously jointly owned or licensed to the Company under the JOMA and the License Agreement.
Niagen Bioscience, Inc. Customers
No clients on recordNo downstream customers found in our database for Niagen Bioscience, Inc..
Niagen Bioscience, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NAGE-DEBT
Debt stack $2.6M
90%
Market cache reports total debt of $2.6M.
NAGE-DEBT-11159
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2019-12-31.
Niagen Bioscience, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Niagen Bioscience, Inc..
Niagen Bioscience, Inc. Ownership
Holder
Name
Confidence
Evidence
NAGE-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 147 tracked holders.
Niagen Bioscience, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.